CoChat
Sign Up
Cited by 791COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchKawasaki Disease and Coronary Complications

Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement

Open access
China National Clinical Research Center for Respiratory Diseases, Shen, Kunling, National Center for Children’s Health, Beijing, China, Group of Respirology, Chinese Pediatric Society, Chinese Medical Association, Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, Chinese Non-government Medical Institutions Association Committee on Pediatrics +22 more·2020·World Journal of Pediatrics
DOI 10.1007/s12519-020-00343-7PMC PMC7090771
Open this paper in CoChat — free accountOpen PDF

Abstract

Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Wuhan City, China, by January 30, 2020, a total of 9692 confirmed cases and 15,238 suspected cases have been reported around 31 provinces or cities in China. Among the confirmed cases, 1527 were severe cases, 171 had recovered and been discharged at home, and 213 died. And among these cases, a total of 28 children aged from 1 month to 17 years have been reported in China. For standardizing prevention and management of 2019-nCoV infections in children, we called up an experts' committee to formulate this experts' consensus statement. This statement is based on the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12519-020-00343-7

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Compared with adults, the pandemic may have increased long-term adverse consequences for children and adolescents.

    “It has been indicated that compared to adults, this pandemic may continue to have increased long term adverse consequences on children and adolescents (Shen et al., 2020).”

    From Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations (2020) · cites this paper as Shen et al., 2020

    The Clinical manifestations section says pediatric COVID-19 symptoms were generally milder than adults’ and that most infected children recovered within 1–2 weeks. The Psychotherapy section mentions possible fear or psychological disorders in older children, but neither section addresses whether the pandemic may have greater long-term adverse consequences for children and adolescents than for adults (searched: long-term adverse consequences and long-term psychological impacts). (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. [2]Zhu N Zhang D Wang W Li X Yang B Song J A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med. 2020 10.1056/NEJMoa2001017 31978945 PMC7092803 · DOI · Paper page
  2. [4]The Society of Pediatrics of Hubei Medical Association The Society of Pediatrics of Wuhan Medical Association Hubei Pediatric Medical Quality Control Center Suggestions on the diagnosis and treatment of novel coronavirus infection in children in Hubei province (trial version 1) CJCP. 2020 22 96 99 32051073 PMC7390014
  3. [5]Chan JF Yuan S Kok KH Wang KK Chu H Yang J A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person to-person transmission: a study of a family cluster Lancet 2020 10.1016/S0140-6736(20)30154-9 31986261 PMC7159286 · DOI
  4. [6]Huang CL Wang YM Li XW Ren LL Zhao JP Hu Y Clinical features of patients infected with 2019 novel coronavirus in Wuhan China Lancet 2020 10.1016/S0140-6736(20)30183-5 31986264 PMC7159299 · DOI · Paper page
  5. [7]Chen NS Zhou M Dong X Qu JM Gong FY Han Y Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 2020 10.1016/S0140-6736(20)30211-7 32007143 PMC7135076 · DOI · Paper page
  6. [8]Li ZZ Shen KL Wei XM Wang HL Lu J Tian H Clinical analysis of pediatric SARS cases in Beijing Chin J Pediatr 2003 41 574 577 14744375
  7. [9]Yang YH Concern for severe acute respiratory syndrom Chin J Pediatr 2003 41 401 402 14748986
  8. [10]Zeng QY Liu L Zeng HS Yu MH Ye QC Deng L Clinical characteristics and prognosis of 33 children with severe acute respiratory syndrome in Guangzhou area Chin J Pediatr 2003 41 408 14748989
  9. [11]Thabet F Chehab M Bafaqih H Al MS Middle East respiratory syndrome coronavirus in children Saudi Med J 2015 36 484 486 10.15537/smj.2015.4.10243 25828287 PMC4404484 · DOI
  10. [13]The Subspecialty Group of Respiratory Diseases of The Society of Pediatrics of Chinese Medical Association Guidelines for management of community acquired pneumonia in children Chin J Pediatr. 2013 51 145 152 24406226
  11. [14]Harris M Clark J Coote N Fletcher P Harnden A McKean M British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 Thorax 2011 66 1 23 10.1136/thoraxjnl-2011-200598 21903691 · DOI
  12. [15]Bradley JS Byington CL Shah SS Alverson B Carter ER Harrison C The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Clin Infect Dis 2011 53 e25 76 10.1093/cid/cir531 21880587 PMC7107838 · DOI
  13. [16]Wang BX Fish EN Global virus outbreaks: interferons as 1st responders Semin Immunol 2019 43 101300 10.1016/j.smim.2019.101300 31771760 PMC7128104 · DOI
  14. [17]Al-Tawfiq JA Momattin H Dib J Memish ZA Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study Int J Infect Dis 2014 20 42 46 10.1016/j.ijid.2013.12.003 24406736 PMC7110882 · DOI
  15. [18]Wang HQ Ma LL Jiang JD Pang R Chen YJ Li YH Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro Acta Pharmaceu Sin 2014 49 1547 1553 25757280
  16. [19]Hijano DR Siefker DT Shrestha B Jaligama S Type I interferon potentiates IgA immunity to respiratory syncytial virus infection during infancy Sci Rep 2018 8 11034 10.1038/s41598-018-29456-w 30038294 PMC6056463 · DOI
  17. [25]Infection group of pediatric branch of Chinese Medical Association National Center for Medical Quality Control of Infectious Diseases Expert consensus on diagnosis and treatment of herpetic pharyngitis (2019 edition) Chin J Pediatr. 2019 57 177 180
  18. [27]Gao H Zhang LL Wei Q Duan ZJ Tu XM Yu ZA Preventive and therapeutic effects of recombinant IFN -α2b nasal spray on SARS-CoV infection in Macaca mulata Chin J Exp Clin Virol 2005 19 207 211 16261198
  19. [28]Yu DX Chen Q Zhang LL Liu Y Yu ZA Li ZF A field trial of recombinant human interferon α-2b for nasal spray to prevent SARS and other respiratory viral infections Chin J Exp Clin Virol 2005 19 216 219 16261200
  20. [29]Chu CM Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 2004 59 252 256 10.1136/thorax.2003.012658 14985565 PMC1746980 · DOI
  21. [32]National Health Commission of People's Republic of China. Influenza diagnosis and treatment protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html. Access 30 Nov 2019.

Cited by

Sorted by citations

Authors
China National Clinical Research Center for Respiratory Diseases, Shen, K., National Center for Children’s Health, B., Group of Respirology, C. P. S., Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, Chinese Non-government Medical Institutions Association Committee on Pediatrics, China Association of Traditional Chinese Medicine, C. O. C. H. A. M. R., China News of Drug Information Association, C. O. C. S. M., Global Pediatric Pulmonology Alliance, Yang, Y., Wang, T., Zhao, D., Jiang, Y., Jin, R., Zheng, Y., Xu, B., Xie, Z., Lin, L., Shang, Y., Lu, X., Shu, S., Bai, Y., Deng, J., Lu, M., Ye, L., Wang, X., Wang, Y., & Gao, L.
Affiliations
  • Capital Medical University (CN)
  • Zhongnan Hospital of Wuhan University (CN)
  • Wuhan Union Hospital (CN)
  • Sheng Jing Hospital (CN)
  • Shenzhen Children's Hospital (CN)
  • Peking University First Hospital (CN)
  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
Corresponding author
  • Shen, Kunling
  • Yang, Yonghong
  • Zhao, Dongchi
ORCID
Venue
World Journal of Pediatrics
Publisher
Springer Science and Business Media LLC
Published
2020-02-07
Volume
16
Issue
3
Pages
223-231
ISSN
  • 1708-8569 (ISSN-L)
  • 1867-0687
DOI
10.1007/s12519-020-00343-7
PMC
PMC7090771
OpenAlex
W3004896587
Cited by
791
References
0
Citations by year
2026: 3 · 2025: 17 · 2024: 43 · 2023: 67 · 2022: 92 · 2021: 191 · 2020: 377 · 2019: 1
FWCI
23.88
Type
journal article
Language
en
Open access
Licence
Locations
  • World Journal of Pediatrics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Surgery › Kawasaki Disease and Coronary Complications
Keywords
SARS-CoV-2, COVID-19 pandemic, pediatric infection, diagnosis, treatment, prevention, children, clinical management
MeSH terms
COVID-19, Child, Humans, Pneumonia, Viral, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review